Ubenimex Bestatin CAS 58970-76-6 Purity ≥99.0% (HPLC) API Factory High Purity

Short Description:

Chemical Name: Ubenimex; Bestatin

CAS: 58970-76-6

Appearance: White to Off-White Powder

Purity: ≥99.0% (HPLC)

Ubenimex: A Potent Aminopeptidase Inhibitor

API High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Manufacturer with High Purity and Stable Quality
Chemical Name: Ubenimex
Synonyms: Bestatin
CAS: 58970-76-6
API High Quality, Commercial Production

Chemical Properties:

Chemical Name	Ubenimex
Synonyms	Bestatin; N-[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl]-L-leucine
CAS Number	58970-76-6
CAT Number	RF-API31
Stock Status	In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula	C16H24N2O4
Molecular Weight	308.37
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	White to Off-White Powder
Infrared Detection	According with CP2010 Standard
Identification	Reactioon with CuSO4 in NaOH Solution, Reaction with 20% Acetic Acid, Ninhydrin and NaOH Solution
Melting Point	~225.0℃ (dec)
Specific Rotation [α]20D	-15.5° ~ -18.0° (C=1 in 1N HCL)
Related Substance (TCL)	One Spot
Purity (HPLC)	≥99.0%
Related Substances	≤1.0%
PH	4.5~7.0
Loss on Drying	≤0.50%
Residue on Ignition	≤0.10%
Heavy Metals	≤20ppm
Assay	≥99.0% (T)
Test Standard	Chinese Pharmacopoeia (CP)
Usage	Active Pharmaceutical Ingredient (API)

Package & Storage:

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Advantages:

FAQ:

Application:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Ubenimex (CAS: 58970-76-6) with high quality. Ubenimex (Bestatin) is a potent aminopeptidase inhibitor.
Ubenimex (CAS: 58970-76-6), also known as Bestatin, a dipeptide N-[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl]-L-leucine is a competitive for leucine aminopeptidase and aminopeptidase-B protease inhibitor. It exerts a direct stimulating effect on lymphocytes (and monocytes) via its fixation on cell surface leucine-aminopeptidase, and an indirect effect on monocytes (and lymphocytes) via aminopeptidase B inhibition of tuftsin catabolism. Ubenimex has also been studied for use in the treatment of acute myelocytic leukemia. Ubenimex has multiple physiological functions including the ability to act as an immunomodifier and enhance the proliferation of human bone marrow granulocyte-macrophage progenitor cells to form CFU-GM colonies. Ubenimex has been used in multiple leukemia studies. Ubenimex is an immunostimulant useful in the treatment of non-lymphocytic leukemia.